Aptevo Therapeutics Inc. — Director's Dealing 2023

Aug 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2023-08-08

Reporting Person: Taylor Daphne (SVP, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-08	Common Stock	M	6945	—	Acquired	12368	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-08	Restricted Stock Unit	$	M	6945	Disposed		Common Stock (6945)	Direct

Footnotes

F1: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2: On August 9, 2022, the reporting person was granted 13,889 RSUs, vesting in two approximately equal installments beginning on August 8, 2023.